Qiuqiang Chen

Key Laboratory For Translational Medicine
Huzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC.

Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC.

Journal: Frontiers in immunology

Published: January 24, 2024

Targeting HER3 to overcome EGFR TKI resistance in NSCLC.

Targeting HER3 to overcome EGFR TKI resistance in NSCLC.

Journal: Frontiers in immunology

Published: November 02, 2023

Game-changing insights on vertebral skeletal stem cells in bone metastasis and therapeutic horizons.

Game-changing insights on vertebral skeletal stem cells in bone metastasis and therapeutic horizons.

Journal: Oncology research

Published: September 14, 2023

Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy.

Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy.

Journal: Oncology research

Published: May 28, 2023

Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors.

Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors.

Journal: Cancers

Published: October 03, 2022

STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.

STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 14, 2022

Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study.

Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study.

Journal: Frontiers in immunology

Published: May 11, 2021

TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.

TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.

Journal: Oncology reports

Published: January 12, 2021

Novel Survivin Peptides Screened With Computer Algorithm Induce Cytotoxic T Lymphocytes With Higher Cytotoxic Efficiency to Cancer Cells.

Novel Survivin Peptides Screened With Computer Algorithm Induce Cytotoxic T Lymphocytes With Higher Cytotoxic Efficiency to Cancer Cells.

Journal: Frontiers in molecular biosciences

Published: June 05, 2020

Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8+ T cell immune responses.

Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8+ T cell immune responses.

Journal: Drug delivery and translational research

Published: June 23, 2019

Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition.

Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition.

Journal: International journal of biological sciences

Published: December 21, 2018

Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer.

Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer.

Journal: Cancer management and research

Published: September 27, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026